Biogen (BIIB) Short term Debt (2010 - 2025)

Biogen's Short term Debt history runs 14 years deep, the most recent figure standing at $150.0 million for Q2 2025.

• In Q2 2025, Short term Debt changed N/A year-over-year to $150.0 million; the TTM figure through Jun 2025 stood at $150.0 million (changed N/A YoY), while the FY2024 annual figure was $1.7 billion, up 1065.73% from the prior year.
• Short term Debt was $150.0 million for Q2 2025 at Biogen, down from $1.7 billion in the prior quarter.
• In the past five years, Short term Debt ranged from a high of $1.7 billion in Q4 2024 to a low of $150.0 million in Q4 2023.
• Historically, Short term Debt has averaged $761.9 million across 4 years, with a median of $574.6 million in 2021.
• Biggest YoY gain for Short term Debt was 1065.73% in 2024; the steepest drop was 1065.73% in 2024.
• A 4-year view of Short term Debt shows it stood at $999.1 million in 2021, then sank by 84.99% to $150.0 million in 2023, then jumped by 1065.73% to $1.7 billion in 2024, then plunged by 91.42% to $150.0 million in 2025.
• The last three Short term Debt figures came in at $150.0 million (Q2 2025), $1.7 billion (Q4 2024), and $150.0 million (Q4 2023), per Business Quant data.